China SXT Pharmaceuticals announces 1-for-150 share consolidation

China SXT Pharmaceutics announced that it will effect a share consolidation of its ordinary shares at a ratio of 1-for-150, effective on February 3, 2026. The Company’s Class A ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on February 3, 2026. Upon the market opening on February 3, 2026, the Company’s Class A ordinary shares will continue to be traded on The Nasdaq Stock Market under the symbol “SXTC”